気管支生検デバイスの世界市場：2023-2030年

気管支生検デバイスの世界市場は、予測期間中にCAGR 7.4％で成長すると予測されています。主な要因としては、肺がん、慢性閉塞性肺疾患（COPD）などの呼吸器疾患の流行、老人人口の増加、低侵襲手技の需要増などが市場成長を牽引しています。肺がん研究財団によると、2023年には米国で推定238,340人が肺がんと診断されます。肺がんは生涯に16人に1人が罹患し、男性では16人に1人、女性では17人に1人が罹患しています。さらに、高齢化社会では呼吸器疾患の傾向が強まり、こうした健康問題に対処するための気管支生検などの診断手技の需要が高まります。2022年11月、記事「高齢者人口統計：A Portrait of Aging Americans」では、米国人口の16.3％にあたる5,410万人が65歳以上の高齢者であると報告されています。高齢者人口は2040年には22.0％、2060年には25.0％に増加すると予想されています。

セグメント別展望

経気管支針吸引（TBNA）針サブセグメントが気管支生検デバイス世界市場でかなりのシェアを占めると予測される

製品の中でも、TBNA針のサブセグメントが気管支生検デバイスの世界市場でかなりのシェアを占めると予測されています。これは、世界的に肺がんの有病率が上昇していることに加え、正確で費用対効果が高く、低侵襲な診断手技に対する需要がTBNA装置の需要に寄与しているためです。米国国立衛生研究所（NIH）によると、過去10年間で、気管支内超音波ガイド下TBNA（EBUS-TBNA）は未診断の胸腔内リンパ節腫脹を評価するための診断手順として好まれるようになりました。EBUS-TBNAは現在、肺がんの縦隔病期分類に適した方法です。Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration：Techniques and Challenges"と題された発表論文によると、インド全土の呼吸器内科医669人のうち、EBUS-TBNAを実施した呼吸器内科医は27.0％に過ぎず、74％は従来のTBNAを使用していました。このような要因から、主要企業は市場での製品需要をケアするために製品を発売せざるを得なくなった。2023年9月、Broncus Medical社は低侵襲診断アプリケーション用の新しいBioStar経気管支吸引針（TBNA）を発表しました。これは従来のTBNA（cTBNA）とEBUS-TBNAの両方の診断技術に使用できるように設計されています。同社はこの針を21G、22G、25Gの構成で提供しています。

地域別展望

気管支生検デバイスの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されます。このうち、アジア太平洋地域は、肺がんの有病率の上昇、結束力のある政府の取り組みや医療政策、新興国における医療インフラの改善が、アジア太平洋地域の気管支生検デバイス市場を牽引していることから、全世界の市場で突出したシェアを占めると予測されています。

北米地域は気管支生検デバイスの世界市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。北米市場は、呼吸器疾患の有病率の上昇とともに、発達した医療部門の存在によって成長しています。さらに、意識の高まり、革新的な気管支生検デバイスに対する需要の増加、医療費の増加が予測期間中の市場成長を促進すると予測されています。経済協力開発機構（OECD）によると、2021年、米国は国内総生産（GDP）の17.8％を医療に費やしており、これはOECD諸国の平均の約2倍です。さらに、メディケア・メディケイド・サービスセンター（CMMS）が2022年3月に発表したデータによると、国民医療費の年間成長率は2021年から2030年にかけて平均5.1％、2030年には約6兆8,000億米ドルに達すると予測されています。GDPの成長率も同期間で年率5.1％と予測されています。同程度の成長率が予測される結果、GDPに占める医療費の割合は2030年には19.6％となり、2020年の19.7％とほぼ同じになると予想されます。したがって、同国における医療支出の増加は、効率的な気管支生検デバイスの開発における企業活動や政府の取り組みを増加させ、市場成長を後押しすると推定されます。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Becton, Dickinson, and Co.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Cook Medical Inc.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• CONMED Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Medtronic plc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 気管支生検デバイスの世界市場：製品別
  • 生検鉗子
  • 経気管支針吸引（TBNA）針
  • 細胞診ブラシ
  • 液体生検機器
• 気管支生検デバイスの世界市場：用途別
  • 病院
  • 画像診断センター
  • 研究・学術機関
  • その他（乳房ケアセンター）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Argon Medical Devices Inc.
• B. Braun Medical Inc.
• Boston Scientific Corp.
• Cardinal Health, Inc.
• F. Hoffmann-La Roche AG
• Fujifilm Corp.
• Hobbs Medical Inc.
• Hologic, Inc.
• Horizons International Corp.
• INRAD Inc.
• NeoGenomics Laboratories, Inc
• Olympus Corp.
• QIAGEN, Inc.
• Stryker Corp.
• Telemed Systems, Inc.

LIST OF TABLES

• 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 2. GLOBAL BIOPSY FORCEPS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
• 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 12. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 13. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 14. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
• 15. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 16. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 17. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
• 18. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 19. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 20. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
• 21. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 22. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 23. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023 VS 2031 (%)
• 2. GLOBAL BIOPSY FORCEPS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023 VS 2031 (%)
• 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 12. US BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 13. CANADA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 14. UK BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 15. FRANCE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 16. GERMANY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 17. ITALY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 18. SPAIN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 19. REST OF EUROPE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 20. INDIA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 21. CHINA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 22. JAPAN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 23. SOUTH KOREA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 24. REST OF ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 25. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)

Global Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration (Tbna) Needles, and Cytology Brushes), and by End-Use (Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Others), Forecast Period (2024-2031)

The global bronchial biopsy devices market is anticipated to grow at a CAGR of 7.4% during the forecast period. Pivotal factors include prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), rising geriatric population, and increasing demand for minimally invasive procedures driving the market growth. According to the Lung Cancer Research Foundation, in 2023, an estimated 238,340 people will be diagnosed with lung cancer in the US. Lung cancer affected 1 in 16 persons in their lifetime 1 in 16 males and 1 in 17 women. Further, the ageing population is more inclined to respiratory diseases, which increases the demand for diagnostic procedures such as bronchial biopsies to address these health issues. In November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060.

Segmental Outlook

The global Bronchial Biopsy Devices market is segmented on the product, and end user. Based on the product, the market is sub-segmented into biopsy forceps, transbronchial needle aspiration (Tbna) needles, and cytology brushes. Further, based on end user, the market is sub-segmented into hospitals, diagnostic imaging centers, research and academic institutes, and others. Other includes breast care centers. Among the end users, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the advance facilities, easily accessible, transportation and housing assistance.

The Transbronchial Needle Aspiration (Tbna) Needles Sub-Segment is Anticipated to Hold a Considerable Share of the Global Bronchial Biopsy Devices Market

Among the product, the TBNA needles sub-segment is expected to hold a considerable share of the global bronchial biopsy devices market, owing to the rising prevalence of lung cancer globally, coupled with the demand for accurate, cost-effective, and minimally invasive diagnostic procedures, contributing to the demand for TBNA devices. According to the National Institutes of Health (NIH), over the past decade, endobronchial ultrasound-guided TBNA (EBUS-TBNA) has become the preferred diagnostic procedure for evaluating undiagnosed intrathoracic lymphadenopathy. EBUS-TBNA is currently the preferred method for mediastinal staging of lung cancer. As per the published article titled "Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Techniques and Challenges," among 669 respiratory physicians throughout India, only 27.0% of surveyed respiratory physicians in India performed EBUS-TBNA, while 74% used conventional TBNA. Such factors compelled the key players to launch product to carer the demand of the product in the market. In September 2023, Broncus Medical introduced the new BioStar Transbronchial Aspiration Needle (TBNA) for minimally invasive diagnostic applications. It has been designed to be used for both conventional TBNA (cTBNA) and EBUS-TBNA diagnostic techniques. The company offers the needle in 21G, 22G and 25G configurations.

Regional Outlook

The global bronchial biopsy devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising prevalence of lung cancer, cohesive government initiatives and healthcare policies, improving healthcare infrastructure in emerging economies are driving the bronchial biopsy devices market in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Bronchial Biopsy Devices Market

Among all regions, North America region is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to the presence of a well-developed healthcare sector, along with the rising prevalence of prevalence of respiratory diseases. Additionally, rising awareness, increasing demand for innovative bronchial biopsy devices, and rising healthcare expenditure are projected to drive market growth during the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is projected to average 5.1% over 2021-2030, and to reach nearly $6.8 trillion by 2030. Growth in the nation's GDP is also anticipated to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the health share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing health spending in the country is estimated to increase company activities and government initiatives in developing efficient bronchial biopsy devices, thus pushing the market growth.

Market Players Outlook

The major companies serving the bronchial biopsy devices market include Becton, Dickinson, and Co., Cook Medical Inc., CONMED Corp., Medtronic plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, Menarini Silicon Biosystems partnered with Alivio Health to expand patient access to CELLSEARCH® liquid biopsy tests. The agreement allowed Alivio Health clients and providers preferred access to CELLSEARCH CTC tests, facilitating longitudinal monitoring of cancer patients at different disease stages.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global bronchial biopsy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Becton, Dickinson, and Co.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Cook Medical Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. CONMED Corp.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Medtronic plc
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Bronchial Biopsy Devices Market by Product
  • 4.1.1. Biopsy Forceps
  • 4.1.2. Transbronchial Needle Aspiration (Tbna) Needles
  • 4.1.3. Cytology Brushes
  • 4.1.4. Liquid Biopsy Instruments
• 4.2. Global Bronchial Biopsy Devices Market by End-Use
  • 4.2.1. Hospitals
  • 4.2.2. Diagnostic Imaging Centers
  • 4.2.3. Research and Academic Institutes
  • 4.2.4. Others (Breast Care Centers)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Argon Medical Devices Inc.
• 6.2. B. Braun Medical Inc.
• 6.3. Boston Scientific Corp.
• 6.4. Cardinal Health, Inc.
• 6.5. F. Hoffmann-La Roche AG
• 6.6. Fujifilm Corp.
• 6.7. Hobbs Medical Inc.
• 6.8. Hologic, Inc.
• 6.9. Horizons International Corp.
• 6.10. INRAD Inc.
• 6.11. NeoGenomics Laboratories, Inc
• 6.12. Olympus Corp.
• 6.13. QIAGEN, Inc.
• 6.14. Stryker Corp.
• 6.15. Telemed Systems, Inc.